Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older
- People who have been diagnosed with drug-resistant epilepsy according to the 2010 International League Against Epilepsy (ILAE) criteria
- People who have had epilepsy for at least 2 years, with seizures happening at least twice per month on average in the 3 months before enrolling
- People who have tried two or more anti-epilepsy medications at adequate doses, and whose treatment plan will remain unchanged during the trial
- People who are able to cooperate with the treatment and complete all required examinations, and who (along with their family) have fully understood and signed a consent form
Who may not be able to join:
- People who are currently experiencing continuous, non-stopping seizures
- People who have serious infections, cerebrovascular disease, cancer, or severe problems with the heart, liver, kidneys, or other major organs
- People who have mental health disorders, uncontrolled high blood sugar that cannot be corrected, or who are taking corticosteroid medications long-term
- People who are pregnant or breastfeeding
- People for whom PET scans, MRI scans, or EEG tests are not safe or suitable
- People who have ferromagnetic (certain types of) metal implants in their body, or who currently have a high fever (confirm with trial site)
- People who are already participating in another clinical trial at the same time
- People whose consent has been withdrawn by themselves or their family
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jiang Wen, Xi Jing hospital
Phone: 18392320919
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The characteristics of hybrid imaging in patients with different types of refractory epilepsy.; The characteristics of PET, fMRI, and EEG indicators in patients with different types of intractable epilepsy.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.